Why Dosage Timing Matters for Treatment Success
GPhC-Registered Pharmacy Wegovy vs Mounjaro Dosage Chart Comparison
When evaluating Wegovy vs Mounjaro dosage schedules, the key difference lies in escalation timing and maintenance phases. Wegovy (semaglutide) follows a structured 16-week escalation: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), then 2.4mg maintenance. Mounjaro (tirzepatide) uses a different approach with 2.5mg starting dose, escalating every 4 weeks to 5mg, 7.5mg, 10mg, and potentially 15mg maximum. EverydayMeds, as GPhC pharmacy #9012878, provides detailed dosing calendars for both treatments to ensure patients understand their specific escalation pathway.
The dosage chart comparison reveals important practical differences between these prescription-only medicines. Wegovy's lower starting dose (0.25mg) may suit those sensitive to gastrointestinal effects, whilst Mounjaro's dual GIP/GLP-1 mechanism requires different dose optimisation. Our Leicester-based clinical team reviews each patient's medical history to determine which dosing schedule aligns with their tolerance and weight management goals. Both treatments require alongside a reduced-calorie diet and increased physical activity, with dosage adjustments individualised based on clinical response and tolerability.
Wegovy vs Mounjaro Dosage Chart Pricing Structure
Understanding the cost implications of different dosage schedules helps inform treatment decisions. Wegovy pricing at EverydayMeds reflects the escalation phases: 0.25mg starter dose £79.99, 0.5mg £94.99, 1mg £99.99, 1.7mg £139.99, with 2.4mg maintenance £209.99. Our Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, providing 12 weeks of initial escalation. New customers use code FIRST40 at checkout, whilst returning patients apply DOSE25 to reach these final prices. The dosage chart comparison shows Mounjaro follows different pricing due to its distinct titration schedule and dual-hormone mechanism.
Bundle options for the Wegovy vs Mounjaro dosage chart reflect different escalation needs. Our Progress Trio (0.5mg, 1mg, 1.7mg) at £369.99 suits patients transitioning through middle doses, whilst the Ultimate Stability Trio (2.4mg ×3) provides £649.99 for three months of maintenance supply. The dosage chart pricing considers that Wegovy requires 16 weeks to reach maintenance versus Mounjaro's potentially longer optimisation period. EverydayMeds structures pricing transparently, with all costs displayed upfront and discount codes clearly explained during the clinical assessment process.
Clinical Evidence Behind Wegovy vs Mounjaro Dosage Charts
The STEP trial programme established Wegovy's dosage escalation schedule through rigorous clinical testing. Wilding et al., NEJM, 2021, demonstrated that the specific 16-week titration to 2.4mg optimised both efficacy and tolerability in weight management. The dosage chart reflects careful balance between therapeutic effect and side effect minimisation, with each escalation phase allowing physiological adaptation to increasing semaglutide levels.
Comparative trials show both medications' dosage charts were designed based on extensive pharmacokinetic studies. Wegovy's dosing schedule achieves steady-state levels whilst minimising gastrointestinal adverse events, particularly during initial weeks. Mounjaro's dosage chart follows different kinetics due to its dual GIP/GLP-1 mechanism requiring alternative dose optimisation strategies. Clinical evidence supports both approaches, with prescriber expertise crucial in determining which dosage timeline suits individual patient circumstances.
How Wegovy Works Throughout Its Dosage Chart
Wegovy functions as a GLP-1 receptor agonist, mimicking the natural incretin hormone that regulates appetite and glucose metabolism. The dosage chart escalation allows gradual receptor activation, reducing appetite progressively whilst promoting satiety after smaller meals. Each dose increase from 0.25mg to 2.4mg enhances GLP-1 receptor binding, strengthening the signals between gut and brain that control food intake. The 16-week escalation schedule ensures patients adapt to these hormonal changes without overwhelming gastrointestinal effects. By maintenance dose, Wegovy works consistently to reduce food cravings and support portion control as part of comprehensive lifestyle modification including reduced-calorie diet and increased physical activity.
Ordering Process for Wegovy vs Mounjaro Dosage Chart Options
EverydayMeds streamlines access to both treatments through our regulated online process designed for prescription-only medicines. The 3-minute clinical assessment captures medical history, current medications, weight management goals, and dosage preferences to help prescribers determine Wegovy vs Mounjaro suitability. UK-licensed prescribers review each consultation within 3 working days (express 24-hour service available), evaluating which dosage schedule aligns with patient needs and contraindication profiles. Once approved, next-day cold-chain delivery ensures medication integrity from our temperature-controlled Leicester facility. Our pharmacy team includes dosage charts, injection guides, and escalation calendars with every order, supporting patients throughout their treatment journey. GPhC registration #9012878 ensures full traceability and regulatory compliance for both Wegovy and Mounjaro supply chains.
Storage Differences in Wegovy vs Mounjaro Dosage Chart Management
Storage requirements differ between these treatments, affecting practical dosage management for UK patients. Wegovy pens require refrigeration at 2-8°C before first use but offer superior travel flexibility with 6 weeks room temperature storage below 30°C once removed from fridge. Mounjaro pens provide only 21 days room temperature storage, making Wegovy more convenient for holidays or business travel during the 16-week escalation phase. Both use pre-filled FlexTouch pen technology for accurate dosing, but the extended room temperature stability gives Wegovy practical advantages during dose escalation periods. Patients following either dosage chart must maintain cold-chain integrity to preserve medication potency, with EverydayMeds providing insulated packaging and storage guidelines for optimal treatment outcomes. The dosage chart flexibility becomes particularly important during summer months or extended travel periods when refrigeration access may be limited.
Regulatory Compliance for Wegovy vs Mounjaro Dosage Chart Supply
EverydayMeds operates under strict MHRA oversight as GPhC-registered pharmacy #9012878, ensuring both Wegovy and Mounjaro dosage charts comply with UK licensing requirements. Our Leicester facility maintains full audit trails for every prescription, from clinical assessment through cold-chain delivery, meeting pharmaceutical quality standards. Licensed prescribers verify BMI eligibility (≥30, or ≥27 with comorbidities) before approving either dosage schedule, ensuring appropriate clinical indication for these prescription-only medicines. The dosage chart comparison requires specialist knowledge of contraindications, drug interactions, and individual patient factors that influence treatment selection.
Regulatory compliance extends throughout the Wegovy vs Mounjaro dosage chart comparison process, with prescribers documenting clinical rationale for treatment choice and dose escalation decisions. EverydayMeds maintains comprehensive patient records, tracking progress through escalation phases and monitoring for adverse effects or dose adjustments. Our GPhC registration enables direct communication with patient GP surgeries, ensuring continuity of care during long-term weight management. The dosage chart selection process includes counselling on lifestyle modifications, realistic expectations, and ongoing clinical monitoring requirements mandated by NICE guidelines for specialist weight management support.
Complete Wegovy vs Mounjaro Dosage Chart Selection Guide
Ready to begin your weight management journey with evidence-based treatment from a trusted GPhC-registered pharmacy? EverydayMeds offers both Wegovy and Mounjaro with comprehensive clinical support, competitive pricing, and next-day delivery throughout the UK. New patients use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our best pricing. Our experienced prescribers will review your clinical assessment and recommend the most suitable dosage chart based on your individual needs, medical history, and treatment goals. Visit https://everydaymeds.co.uk/collections/wegovy to start your 3-minute assessment today. With GPhC pharmacy #9012878 backing every prescription, you can trust EverydayMeds for safe, effective, and professionally managed weight loss treatment that puts your health first.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
